Location: online webinar

Opportunities for Proteomics in Cancer Research
This one-hour statewide virtual seminar will explore mass spectrometry-based proteomics as a cutting-edge frontier in cancer research. Participants will learn how proteomic data can transform patient care by enabling more precise risk stratification, treatment selection, and improved disease classification. Led by leading experts in translational cancer proteomics, the session is designed to be accessible and relevant to clinicians, researchers, and allied health professionals.

Speakers:
Dr Rebecca Poulos. Group Leader, Multi-Omics in Childhood Cancer, Children’s Medical Research Institute; Sydney Cancer Partners Translational Partners Fellow.
Dr Bhavna Padhye. Senior Staff Specialist and Paediatric Oncologist, The Children’s Hospital at Westmead; Sydney Cancer Partners Translational Partners Fellow.
Dr Liz Connolly. Medical Oncologist, Peter MacCallum Cancer Centre; Oncology Research Fellow, Children’s Medical Research Institute.
Dr Adel Aref. Lead, ProCan® Oncology, Children’s Medical Research Institute.

Chair: Clinical Professor Rosemary Balleine, Clinical and Strategic Partnerships Lead, Sydney Cancer Partners.

Session Overview
Overview of Proteomics of Cancer – Rebecca Poulos
Neuroblastoma proteomics – Bhavna Padhye
Leiomyosarcoma proteomics – Liz Connolly
Colorectal cancer proteomics – Adel Aref

Related Education & Resources

  • Dr Tiffany Li – Multinational Association of Supportive Care in Cancer | June 2026

    Type of resource:
  • Sharlyn Tan – Multinational Association of Supportive Care in Cancer | June 2026

    Type of resource:
  • Dr Faiqa Mudassar – 22nd International Symposium on Pediatric Neuro-Oncology | June 2026

    Type of resource: